HS5 - Arterial Thrombosis Flashcards

1
Q

What is thrombosis?

A

• Too much platelet activity or excessive coagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Arterial thrombosis occurs when which form of haemostasis has gone wrong?

A

• Primary haemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Venous thrombosis occurs when which form of haemostasis has gone wrong

A

• Secondary haemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where does arterial thrombosis tend to occur?

A

• At the site of an atheroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is an atheroma?

A

• A buildup of fatty deposits with a fibrous cap In the wall of a blood vessel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When a calcified plaque ruptures why does this course a thrombosis to occur?

A

• Blood is exposed to procoagulant and platelet activating substances such as collagen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What sort of cells do you find in atherosclerotic plaques?

A

• Foam cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are foam cells formed?

A

• Monocytes migrate to plaque
• become macrophages
• become engorged on fatty material
and then die

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When a plaque ruptures blood is exposed to tissue factor this causes the conversion of prothrombin to what?

A

• Thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When a plaque ruptures the exposure of blood to tissue factor and collagen results in the formation of what at the site of the ruptured plaque?

A

• Platelet plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drug treatment strategies for treating arterial thrombosis relies on trying to stop platelets aggregating by targeting 3 things what are they?

A
  • Inhibition of platelets
  • inhibition of fibrin formation
  • augmentation of fibrinolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name 5 types of antithrombotic drugs used to treat arterial thrombosis.

A
  • Aspirin
  • heparin
  • ADP receptor antagonists (clopidogrel, prasugrel)
  • platelet GPIIb/IIIa inhibitors (ReoPro, tirofiban)
  • thrombolytics (streptokinase, tPA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3 types of surgical interventions are used to treat arterial thrombosis, name these.

A
  • Balloon angioplasty (PTCA)
  • stenting
  • CABG (coronary artery bypass grafts)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the side-effects of aspirin?

A
  • Dyspepsia
  • heartburn
  • GI bleeding
  • allergy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name 2 types of second-generation platelet inhibitors.

A
  • Clopidogrel

* GPIIb/IIIa inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clopidogrel is a second-generation platelet inhibitor, what does it target?

A

• P2Y12 ADP Receptor

17
Q

Clopidogrel is an irreversible antagonist of what?

A

• P2Y12 ADP Receptor

18
Q

What is the effect of clopidogrel on platelets?

A

• It blocks the effect of ADP on platelets

19
Q

clopidogrel is a pro-drug so what needs to happen to it before it becomes active?

A

• Metabolised in the liver

20
Q

What do GPIIb/IIIa inhibitors do?

A

• Stop fibrinogen binding to platelet receptors

21
Q

GPIIb/IIIa stop fibrinogen binding to platelet receptors so they completely block what?

A

• Aggregation

22
Q

What is one problem with clopidogrel?

A

• Liver metabolism, rates of metabolism varies between individuals - some people don’t respond.

23
Q

Ticagrelor is a third-generation platelet inhibitor with 3 main benefits what are these?

A
  • No need for prodrug metabolism
  • reversible antagonist
  • orally active
24
Q

What type of enzyme is thrombin?

A

• Protease

25
Q

How does thrombin activate platelets?

A
  • Chops terminal NH2 off protease activating receptor-1 (PAR-1) on the surface of platelets.
  • residual tethered ligand folds back and binds to a different part of the receptor
  • auto activates the receptor